Hematoporphyrin monomethyl ether sonodynamic therapy (HMME-SDT) mitigates keloid scarring via the PI3K-AKT signaling pathway
HMME-SDT, with its anti-proliferative and anti-fibrotic properties, presents a promising therapeutic strategy for the treatment of keloid.
Authors
- Xiaoyu Zhai (ORCID: https://orcid.org/0000-0001-9663-622X)
- Zhinan Shi
- Min Li (ORCID: https://orcid.org/0000-0002-8923-289X)
- Liqun Gu (ORCID: https://orcid.org/0000-0003-3208-1186)
- Siqi Shen (ORCID: https://orcid.org/0000-0003-1661-1247)
- Li H. Gu (ORCID: https://orcid.org/0000-0001-7044-6444)
- Jing Zhao (ORCID: https://orcid.org/0009-0009-0139-5538)
- Lin Chen (ORCID: https://orcid.org/0000-0001-7905-2505)
- Shu Zhou (ORCID: https://orcid.org/0000-0002-6133-3007)
- Hui Hua (ORCID: https://orcid.org/0000-0002-8229-5492)
- Jing Wang (ORCID: https://orcid.org/0009-0001-4936-6244)
- Bingrong Zhou (ORCID: https://orcid.org/0000-0002-9940-0519)
- Zhiyi Xu
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Photodiagnosis and Photodynamic Therapy
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1016/j.pdpdt.2025.104593
- Citations
- 1
- Primary Topic
- Dermatologic Treatments and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.00